FFAR1 and Hypoglycemia: Our theoretical analysis shows that activators of GLP-1, GIP and FFAR1/GPR40 receptors may have a low risk of hypoglycemia because they need a concomitant increase in [Ca2+]c for activation whereas an activator of muscarinic receptors can lead to hypoglycemia.